It has been suggested that mGluR5 is involved in CNS disorders that are induced by the hypersecretion of glutamate, such as epilepsy, neurogenic or inflammatory pain, psychosis, dyskinesia, headaches and drug addiction [16,17]. Here, GRM5 is linked to epilepsy.